Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Takeru Funakoshi

15PUBLICATIONS
56CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Mortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Mar 04, 2026
Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Yoshio Nakamura, Naoya Yamazaki, Kenjiro Namikawa

|Apr 04, 2025
Adjuvant Anti-PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients.

Shigeru Koizumi, Naoya Yamazaki, Yuki Ichigozaki

|Jun 01, 2024
Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).

Ikuko Hirai, Keiji Tanese, Yoshio Nakamura

|Feb 16, 2024
Proposal for the optimal staging of extramammary Paget's disease: A retrospective analysis of 57 cases with distant metastasis.

Takeru Funakoshi, Yoshio Nakamura, Ikuko Hirai

|Jan 29, 2024
Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial.

Takuya Maeda, Teruki Yanagi, Keiko Tokuchi

|Dec 08, 2022
Congenital dermatofibrosarcoma protuberans presenting as a depressed plaque: Clinical presentation and chronology.

Yuuri Nakajima, Takayuki Fusumae, Ikuko Hirai

Pageof 3

Frequent Collaborators

3 joint publications

Keiji Tanese

3 joint publications

Yoshio Nakamura

3 joint publications

Ikuko Hirai

3 joint publications

Keitaro Fukuda

2 joint publications

Takayuki Fusumae

2 joint publications

Yuki Yamamoto

2 joint publications

Shigeto Matsushita

1 joint publications

Yasuhiro Nakamura

1 joint publications

Chihiro Shiiya

1 joint publications

Takeshi Ouchi

Frequent Collaborators

3 joint publications

Keiji Tanese

3 joint publications

Yoshio Nakamura

3 joint publications

Ikuko Hirai

3 joint publications

Keitaro Fukuda

Top Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

12.4K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

12.3K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.2K
See more related videos

Top Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

12.4K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

12.3K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.2K
See more related videos